UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 56

Sortiert nach

Pancreas volumes in humans from birth to age one hundred taking into account sex, obesity, and presence of type-2 diabetes

Clinical anatomy (New York, N.Y.), 2007-11, Vol.20 (8), p.933-942

2007

Link zum Volltext

Verfügbarkeit prüfen

Performance of 2-deoxy-2-[F-18]fluoro-D-glucose positron emission tomography and integrated PET/CT in restaged breast cancer patients

Molecular imaging and biology, 2005-09, Vol.7 (5), p.369-376

2005

Link zum Volltext

Verfügbarkeit prüfen

Death from Metastatic Donor‐Derived Ovarian Cancer in a Male Kidney Transplant Recipient

American journal of transplantation, 2009-02, Vol.9 (2), p.428-432

2009

Link zum Volltext

Verfügbarkeit prüfen

SPECT- and PET-Based Patient-Tailored Treatment in Neuroendocrine Tumors: A Comprehensive Multidisciplinary Team Approach

Clinical nuclear medicine, 2015-05, Vol.40 (5), p.e271-e277

2015

Link zum Volltext

Verfügbarkeit prüfen

Oncologic PET/CT interpretation and reporting approaches. Survey in clinical practice

Nuclear medicine, 2014, Vol.53 (2), p.19

2014

Link zum Volltext

Verfügbarkeit prüfen

Novel features in a patient homozygous for the L347P mutation in the PINK1 gene

Parkinsonism & related disorders, 2007-08, Vol.13 (6), p.359-361

2007

Link zum Volltext

Verfügbarkeit prüfen

Malignant Pheochromocytoma Presenting as a Large Adrenal Mass With Cavoatrial Tumor Thrombus

AACE clinical case reports, 2024-05, Vol.10 (3), p.117-118

2024

Link zum Volltext

Verfügbarkeit prüfen

Standard PET/CT of the Chest During Shallow Breathing Is Inadequate for Comprehensive Staging of Lung Cancer

The Journal of nuclear medicine (1978), 2006-02, Vol.47 (2), p.298-301

2006

Link zum Volltext

Verfügbarkeit prüfen

Diagnostic Nuclear Medicine

2nd ed., 2005

Link zum Volltext

Verfügbarkeit prüfen

Comparison between 2-deoxy-2-[ 18F]fluoro-D-Glucose positron emission tomography and positron emission tomography/computed tomography hardware fusion for staging of patients with lymphoma

Molecular imaging and biology, 2004-11, Vol.6 (6), p.411-416

2004

Link zum Volltext

Verfügbarkeit prüfen

PET/Computed Tomography and Lymphoma

The Radiologic clinics of North America, 2013-09, Vol.51 (5), p.833-844

2013

Link zum Volltext

Verfügbarkeit prüfen

The Impact of Fluorodeoxyglucose–Positron Emission Tomography in Primary Staging and Patient Management in Lymphoma Patients

The Radiologic clinics of North America, 2008-03, Vol.46 (2), p.199-211

2008

Link zum Volltext

Verfügbarkeit prüfen

Diagnostic Nuclear Medicine

2nd Revised Edition

Link zum Volltext

Verfügbarkeit prüfen

Relationship between coronary function by positron emission tomography and temporal changes in morphology by intravascular ultrasound (IVUS) in transplant recipients

The Journal of heart and lung transplantation, 1999-03, Vol.18 (3), p.211-219

1999

Link zum Volltext

Verfügbarkeit prüfen

Tumor FDG-uptake after the initial cycle of chemotherapy and histopathologic response to neoadjuvant therapy in high-grade soft tissue sarcomas

Journal of clinical oncology, 2008-05, Vol.26 (15_suppl), p.10528-10528

2008

Link zum Volltext

Verfügbarkeit prüfen

Change in quantitative FDG-PET was significantly more accurate than change in size at predicting histopathologic response to neoadjuvant therapy in high grade soft tissue sarcomas

Journal of clinical oncology, 2007-06, Vol.25 (18_suppl), p.10017-10017

2007

Link zum Volltext

Verfügbarkeit prüfen

Quantitative F18‐fluorodeoxyglucose positron emission tomography accurately characterizes peripheral nerve sheath tumors as malignant or benign

Cancer, 2010-01, Vol.116 (2), p.451-458

2010

Link zum Volltext

Verfügbarkeit prüfen

PSMA PET/CT Dual-Time-Point Imaging: Nice to Have or Need to Have?

The Journal of nuclear medicine (1978), 2024-05, Vol.65 (5), p.818

2024

Link zum Volltext

Verfügbarkeit prüfen

Nuclear Medicine Operations in the Times of COVID-19: Strategies, Precautions, and Experiences

Journal of Nuclear Medicine, 2020-05, Vol.61 (5), p.626-629

2020

Link zum Volltext

Verfügbarkeit prüfen

FDG-PET/CT Imaging Predicts Histopathologic Treatment Responses after the Initial Cycle of Neoadjuvant Chemotherapy in High-Grade Soft-Tissue Sarcomas

Clinical cancer research, 2009-04, Vol.15 (8), p.2856-2863

2009

Link zum Volltext

Verfügbarkeit prüfen

3′‐deoxy‐3′‐[18F]fluorothymidine positron emission tomography for response assessment in soft tissue sarcoma

Cancer, 2012-06, Vol.118 (12), p.3135-3144

2012

Link zum Volltext

Verfügbarkeit prüfen

PET Imaging of Prostate Cancer Using11 C-Acetate

PET clinics, 2009, Vol.4 (2), p.163-172

2009

Link zum Volltext

Verfügbarkeit prüfen

3'-deoxy-3'-[18F]fluorothymidine positron emission tomography for response assessment in soft tissue sarcoma: a pilot study to correlate imaging findings with tissue thymidine kinase 1 and Ki-67 activity and histopathologic response

Cancer, 2012-06, Vol.118 (12), p.3135-3144

2012

Link zum Volltext

Verfügbarkeit prüfen

Reduction of Glucose Metabolic Activity Is More Accurate than Change in Size at Predicting Histopathologic Response to Neoadjuvant Therapy in High-Grade Soft-Tissue Sarcomas

Clinical cancer research, 2008-02, Vol.14 (3), p.715-720

2008

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 56

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(52)
Mit Volltextzugriff
(49)

Publikationsform

Artikel
(54)
Bücher
(2)

Sprache

Englisch
(56)
Japanisch
(11)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

Humans
(30)
Life Sciences & Biomedicine
(22)
Science & Technology
(22)
Male
(20)
Female
(16)
Middle Aged
(16)
Aged
(14)
Radiology, Nuclear Medicine & Medical Imaging
(13)
Adult
(11)
Oncology
(11)
Positron-Emission Tomography
(10)
Tomography, X-Ray Computed
(10)
Aged, 80 And Over
(9)
Tumors
(9)
Biological And Medical Sciences
(8)
Medical Sciences
(8)
Nuclear Medicine
(7)
Pet/ct
(7)
Radiopharmaceuticals
(7)
Fluorodeoxyglucose F18
(6)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Pancreas volumes in humans from birth to age one hundred taking into account sex, obesity, and presence of type-2 diabetes

Performance of 2-deoxy-2-[F-18]fluoro-D-glucose positron emission tomography and integrated PET/CT in restaged breast cancer patients

Death from Metastatic Donor‐Derived Ovarian Cancer in a Male Kidney Transplant Recipient

SPECT- and PET-Based Patient-Tailored Treatment in Neuroendocrine Tumors: A Comprehensive Multidisciplinary Team Approach

Oncologic PET/CT interpretation and reporting approaches. Survey in clinical practice

Novel features in a patient homozygous for the L347P mutation in the PINK1 gene

Malignant Pheochromocytoma Presenting as a Large Adrenal Mass With Cavoatrial Tumor Thrombus

Standard PET/CT of the Chest During Shallow Breathing Is Inadequate for Comprehensive Staging of Lung Cancer

Diagnostic Nuclear Medicine

Comparison between 2-deoxy-2-[ 18F]fluoro-D-Glucose positron emission tomography and positron emission tomography/computed tomography hardware fusion for staging of patients with lymphoma

PET/Computed Tomography and Lymphoma

The Impact of Fluorodeoxyglucose–Positron Emission Tomography in Primary Staging and Patient Management in Lymphoma Patients

Diagnostic Nuclear Medicine

Relationship between coronary function by positron emission tomography and temporal changes in morphology by intravascular ultrasound (IVUS) in transplant recipients

Tumor FDG-uptake after the initial cycle of chemotherapy and histopathologic response to neoadjuvant therapy in high-grade soft tissue sarcomas

Change in quantitative FDG-PET was significantly more accurate than change in size at predicting histopathologic response to neoadjuvant therapy in high grade soft tissue sarcomas

Quantitative F18‐fluorodeoxyglucose positron emission tomography accurately characterizes peripheral nerve sheath tumors as malignant or benign

PSMA PET/CT Dual-Time-Point Imaging: Nice to Have or Need to Have?

Nuclear Medicine Operations in the Times of COVID-19: Strategies, Precautions, and Experiences

CD19/CD20 Bispecific Chimeric Antigen Receptor (CAR) in Naive/Memory T Cells for the Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma

FDG-PET/CT Imaging Predicts Histopathologic Treatment Responses after the Initial Cycle of Neoadjuvant Chemotherapy in High-Grade Soft-Tissue Sarcomas

3′‐deoxy‐3′‐[18F]fluorothymidine positron emission tomography for response assessment in soft tissue sarcoma

PET Imaging of Prostate Cancer Using11 C-Acetate

3'-deoxy-3'-[18F]fluorothymidine positron emission tomography for response assessment in soft tissue sarcoma: a pilot study to correlate imaging findings with tissue thymidine kinase 1 and Ki-67 activity and histopathologic response

Reduction of Glucose Metabolic Activity Is More Accurate than Change in Size at Predicting Histopathologic Response to Neoadjuvant Therapy in High-Grade Soft-Tissue Sarcomas

Suchergebnisse filtern